The global clinical trial supply and logistics market is set for substantial growth, driven by the rising demand for innovative therapies and the increasing number of clinical trials worldwide. As pharmaceutical and biotechnology companies develop more complex and personalised medicines, efficient and reliable supply chain management becomes paramount.
The globalisation of clinical trials, with studies spanning multiple regions and countries, has further fuelled demand for specialist logistics services ensuring timely and compliant delivery of trial materials. Technological advancements, such as digital tools for supply chain management, real-time tracking, and cold chain logistics, are enhancing efficiency and reliability.
Market Size & Growth:
In 2023, the market for clinical trial supply and logistics was valued at £18.2 billion. From 2024 to 2030, total revenue is projected to rise at a compound annual growth rate (CAGR) of 9.10%, reaching a market value of £33.3 billion by 2030.
Market Segmentation:
The market is segmented by service type, with the largest share held by Logistics & Distribution in 2023, representing 25% of the total market. This segment is anticipated to exhibit the fastest growth rate in the coming years.
By end user, the market is divided into:
Pharmaceuticals: The dominant segment, representing 41% of the market in 2023, driven by increased clinical trial activity and investment in research and development by pharmaceutical companies.
Biologicals: Holding a 28% market share in 2023, this segment is the second largest and is projected to experience the highest CAGR during the forecast period.
Medical Devices: This segment holds a significant share of the market and is anticipated to witness steady growth in the coming years.
Regional Analysis:
The research provides detailed insights into the market dynamics across regions including the Middle East, South America, Europe, Africa, and the Asia-Pacific. The report analyses product imports and exports by countries and regions, along with market size and growth rates, offering a comprehensive overview of the latest developments in various regions.
Key Players and Market Outlook:
The report identifies key players in the clinical trial supply and logistics market, including:
1. Piramal Pharma Solutions
2. UDG Healthcare
3. DHL
4. FedEx
5. Movianto
6. Packaging Coordinators Inc.
7. Thermo Fisher Scientific (Patheon)
8. Catalent, Inc.
9. Parexel
10. Almac Group
11. Marken
12. Merck & Co. Inc.
13. GlaxoSmithKline plc
The research highlights key questions answered in the report, providing a comprehensive understanding of the market landscape:
What is clinical trial supply and logistics?
What is the growth rate of the market?
What factors are driving market growth?
What are the different market segments?
What growth strategies are players employing to expand their presence?
What are the emerging industry applications and trends?
What challenges could the market face in the future?
Who are the leading companies and their portfolios?
Conclusion:
The clinical trial supply and logistics market is poised for robust growth in the coming years, driven by a confluence of factors including the increasing number of clinical trials, advancements in drug development, and the globalisation of research. As the demand for new and innovative therapies continues to rise, efficient and reliable supply chain management will be crucial for the success of clinical trials and the development of life-saving treatments.